Investments in the orthopedic care sector have reached notable heights, fueled by increasing health spending globally. Accurate estimates of health expenditures are crucial for effective health policy and planning, playing a pivotal role in attaining national and international health objectives. A report from the World Health Organization (WHO) released on February 20, 2019, highlighted a 6% increase in global health spending in low- and middle-income countries and a 4% increase in high-income countries. However, governments contribute less than 40% to primary health care spending, creating opportunities for private sector involvement.
The allure of the orthopedic care sector is drawing numerous companies due to its high market potential. Existing players are actively investing in research and development to incorporate advanced technologies into their portfolios, ensuring they remain competitive and maintain their market share.
In the United States, healthcare spending in 2018 was estimated to exceed $10,000 per resident. A significant portion of this spending is directed toward planned knee and hip replacement procedures, a trend noted in a review of medical claims data from 2010 to 2017 by the Blue Cross Blue Shield Association. Knee replacements have seen a 17% increase, while hip replacements have surged by 33%. Orthopedic surgeries, particularly planned ones, accounted for over $25 billion in 2017, constituting 47% of total orthopedic spending鈥攁 substantial 44% rise since 2010.
In response to the growing demand, healthcare companies are establishing orthopedic care centers globally. For instance, Hartford HealthCare launched its $150 million, 130,000-square-foot Bone and Joint Institute in early 2017, while Bristol Hospital is opening a $25.3 million, 60,000-square-foot ambulatory care center in Bristol, focusing on orthopedic and other services. Projections from the American Academy of Orthopaedic Surgeons (AAOS) indicate a 189% increase in total knee replacements, reaching nearly 1.3 million by 2030 and surging to approximately 2.6 million by 2060. This anticipated growth presents significant opportunities for the bone graft substitute market in the forecast years.
In conclusion, the orthopedic care sector is experiencing substantial investments and growth, driven by increased health spending globally. Private sector participation is rising, and companies are channeling resources into research and development to stay ahead in this competitive landscape. The surge in planned orthopedic surgeries, especially knee and hip replacements, is contributing to a burgeoning market with the establishment of orthopedic care centers to meet the growing demand. Projections for the future underscore the continued expansion of the orthopedic care sector, presenting considerable opportunities for the bone graft substitute market.
Report Attribute/Metric | Details |
---|---|
Segment Outlook | Product, Material, Application, End user Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors Aesculap Implant System LLp, Integra Lifesciences Corporation, Johnson & Johnson, Kanghui Orthopedic, KLS Martin, MATRIX SURGICAL USA, Medartis AG, Medtronic, OsteoMed, Stryker Corporation, TMJ Concepts, L. Gore and Associates Key Market Opportunities New product launches and R&D Amongst major key Players Key Market Drivers路 Increasing participation of key players路 Acceptance of craniomaxillofacial (CMF) devices in ambulatory settings路 Increasing geriatric population路 Untapped emerging markets路 Rise in regulatory approvals路 Growing demand for bioresorbable devices |
Craniomaxillofacial Devices Market Size was valued at USD 1.88 Billion in 2023. The Global Craniomaxillofacial Devices industry is projected to grow from USD 2.06 Billion in 2024 to USD 4.32 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.23% during the forecast period (2024 - 2032).
The increasing participation of key players is one of the key factors driving the craniomaxillofacial (CMF) devices market. In 2019, Kelyniam Global (KLYG) received premarket FDA approval for unique modifications to their PEEK cranio-maxillofacial implant product line.
Various other factors such as the acceptance of craniomaxillofacial (CMF) devices in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and growing demand for bioresorbable devices are also expected to propel the growth of the Craniomaxillofacial (CMF) Devices Market.
However, the low success rate of surgical procedures, and high costs and shortcomings of titanium implants can hamper craniomaxillofacial (CMF) devices market growth over the forecast period.
The craniomaxillofacial devices market is segmented based on product, material, application, end user, and region.
The global craniomaxillofacial (CMF) devices market, by product, is segmented into cranial flap fixation, craniomaxillofacial fixation (CMF) distraction, temporomandibular joint replacement, thoracic fixation, bone graft substitute, CMF plate and screw fixation, and dural repair. The dural repair segment is further classified as dural sealants and dural substitutes.
Based on material, the Craniomaxillofacial (CMF) Devices market is segmented into metals and alloys, bioabsorbable, ceramics, polymers, and others.
Based on application, the Craniomaxillofacial (CMF) Devices market is segmented into neurosurgery, ENT, orthognathic & dental surgery, plastic surgery, and others.
Based on end user, the Craniomaxillofacial (CMF) Devices market is segmented into hospitals, ambulatory surgical centers, and others.
In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.
The craniomaxillofacial devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European craniomaxillofacial devices market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The craniomaxillofacial devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The craniomaxillofacial devices market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
The Americas dominated the global market for CMF devices owing to the rising number of craniofacial surgeons within the region. As per the 2017 data published in the Journal of Surgical Education, the number of craniofacial surgery fellowship graduates were increasing. It was reported that around 175 craniofacial surgeons were trained at 35 fellowship programs in 2017. Rising participation of market players is also strongly impacting the growth of the Americas craniomaxillofacial (CMF) devices market. For instance, in 2016, the US- and Brazil-based company, BioArchitects received FDA approval for 3D-printed titanium cranial/maxillofacial implant. This 3D Printing uses electron beam melting technology, which involves using electron beams to melt and fuse very fine metal powder.
In 2018, it was estimated that Europe stood second in the global Craniomaxillofacial (CMF) Devices market. Technological advancements, along with the availability of funding opportunities in research and innovation, will support market growth.
Asia-Pacific (APAC) is expected to represent the phenomenal CMF devices market growth throughout the forecast period due to rising prevalence of chronic conditions, growing awareness about CMF devices, and rising demand for minimally invasive surgeries. The population in developing economies is focusing towards minimally invasive procedures to treat a variety of medical and aesthetic imperfections.
On the other hand, the Middle East and Africa held the least share in the global CMF devices market due to the low economic development, especially within the African region.
Research Methodology
Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research ( 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.
Intended Audience
漏 2024 Market Research Future 庐 (Part of WantStats Reasearch And Media Pvt. Ltd.)